Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy
Authors
Keywords
-
Journal
IUBMB LIFE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-08-25
DOI
10.1002/iub.2773
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Karyopherin Subunit Alpha 1 Enhances the Malignant Behaviors of Colon Cancer Cells via Promoting Nuclear Factor-κB p65 Nuclear Translocation
- (2023) Lianrong Zhao et al. DIGESTIVE DISEASES AND SCIENCES
- Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling
- (2023) Huideng Long et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selinexor as Novel Inhibitor of DNA Damage Response in Merkel Cell Carcinoma
- (2022) Stephen A. Moore et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms
- (2022) Suresh Kumar Balasubramanian et al. LEUKEMIA
- Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia
- (2022) Hanxi Yu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Selinexor improves the anti-cancer effect of tucidinostat on TP53 wild-type breast cancer
- (2022) Yingfang Shi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present
- (2022) Patriciu Achimas-Cadariu et al. Journal of Ovarian Research
- Combining selinexor with alisertib to target the p53 pathway in neuroblastoma
- (2022) Rosa Nguyen et al. NEOPLASIA
- Tumor-promoting properties of karyopherin β1 in melanoma by stabilizing Ras-GTPase-activating protein SH3 domain-binding protein 1
- (2022) Fan Yang et al. CANCER GENE THERAPY
- Inhibition of karyopherin β1-mediated nuclear import disrupts oncogenic lineage- defining transcription factor activity in small cell lung cancer
- (2022) Demetra P. Kelenis et al. CANCER RESEARCH
- Enhancement of MDM2 inhibitory effects through blocking nuclear export mechanisms in ovarian cancer cells
- (2022) Amal Alzahrani et al. Cancer Genetics
- Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
- (2022) Kristina B. Emdal et al. Cell Reports
- Inhibition of XPO1 impairs cholangiocarcinoma cell proliferation by triggering p53 intranuclear accumulation
- (2022) Cheng Zhao et al. Cancer Medicine
- GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells
- (2022) Yue Zhang et al. ONCOGENE
- XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3a
- (2021) Jingya Wang et al. CANCER LETTERS
- Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer
- (2021) Ru-pin Alicia Chi et al. BMC CANCER
- Downregulation of c-Myc expression confers sensitivity to CHK1 inhibitors in hematologic malignancies
- (2021) Kai-long Jiang et al. ACTA PHARMACOLOGICA SINICA
- Novel small molecule inhibitor of Kpnβ1 induces cell cycle arrest and apoptosis in cancer cells
- (2021) Aderonke Ajayi-Smith et al. EXPERIMENTAL CELL RESEARCH
- Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer
- (2021) Akira Inoue et al. GASTROENTEROLOGY
- Clinical acquired resistance to KRASG12C inhibition through a novel KRAS switch-II pocket mutation and polyclonal alterations converging on RAS-MAPK reactivation
- (2021) Noritaka Tanaka et al. Cancer Discovery
- Repositioning of Antiparasitic Drugs for Tumor Treatment
- (2021) Yan-Qi Li et al. Frontiers in Oncology
- TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer
- (2021) Bikang Yang et al. CANCER LETTERS
- Metabolic reprograming confers tamoxifen resistance in breast cancer
- (2021) Alok Mishra et al. CHEMICO-BIOLOGICAL INTERACTIONS
- XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB
- (2021) Basia Galinski et al. Translational Oncology
- Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status
- (2021) Hélène Marijon et al. Oncotarget
- Circular RNA circ-TNPO3 suppresses metastasis of gastric cancer by acting as a protein decoy for IGF2BP3 to regulate the expression of MYC and SNAIL
- (2021) Ting Yu et al. Molecular Therapy-Nucleic Acids
- Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy
- (2021) Alvaro Quintanal-Villalonga et al. CANCER RESEARCH
- Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma
- (2021) Rikio Suzuki et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer
- (2021) Narmeen S. Rashid et al. Translational Oncology
- Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesis
- (2021) Lei Zhao et al. Translational Cancer Research
- KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer
- (2021) Ho Tsoi et al. Clinical and Translational Medicine
- Selinexor for the treatment of multiple myeloma
- (2020) Klaus Podar et al. EXPERT OPINION ON PHARMACOTHERAPY
- Identification of Prognostic Dosage-Sensitive Genes in Colorectal Cancer Based on Multi-Omics
- (2020) Zhiqiang Chang et al. Frontiers in Genetics
- G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Granules
- (2020) Peiguo Yang et al. CELL
- Efficient Suppression of NRAS-Driven Melanoma by Co-inhibition of ERK1/2 and ERK5 MAPK Pathways
- (2020) Christian Adam et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Small Molecule Inhibitors of CRM1
- (2020) Bibiana I. Ferreira et al. Frontiers in Pharmacology
- Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status
- (2020) Man Yee Keung et al. Journal of Clinical Medicine
- Targeting nuclear import and export in hematological malignancies
- (2020) Boaz Nachmias et al. LEUKEMIA
- Recognition of nuclear export signals by CRM1 carrying the oncogenic E571K mutation
- (2020) Jordan M. Baumhardt et al. MOLECULAR BIOLOGY OF THE CELL
- Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer
- (2020) Yang Zhou et al. ONCOGENE
- G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer
- (2020) Junjie Zhao et al. BRITISH JOURNAL OF CANCER
- Melphalan and exportin 1 inhibitors exert synergistic anti-tumor effects in preclinical models of human multiple myeloma
- (2020) Joel G Turner et al. CANCER RESEARCH
- PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
- (2020) Rui Liu et al. Cell Death & Disease
- Inhibition of Karyopherin beta 1 suppresses prostate cancer growth
- (2019) Jian Yang et al. ONCOGENE
- Importin-4 functions as a driving force in human primary gastric cancer
- (2019) Xia Xu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer
- (2019) Michael Shafique et al. ONCOLOGIST
- Inhibitors of nuclear transport
- (2019) David A Jans et al. CURRENT OPINION IN CELL BIOLOGY
- Altered nuclear export signal recognition as a driver of oncogenesis
- (2019) Justin Taylor et al. Cancer Discovery
- pCRM1exportome: database of predicted CRM1-dependent Nuclear Export Signal (NES) motifs in cancer-related genes
- (2019) Yoonji Lee et al. BIOINFORMATICS
- Importin-β/karyopherin-β1 modulates mitotic microtubule function and taxane sensitivity in cancer cells via its nucleoporin-binding region
- (2019) Annalisa Verrico et al. ONCOGENE
- Treatment Options for Triple-class Refractory Multiple Myeloma
- (2019) Joseph Mikhael Clinical Lymphoma Myeloma & Leukemia
- CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity
- (2019) Youzhou Sang et al. Nature Communications
- TNPO2 operates downstream of DYNC1I1 and promotes gastric cancer cell proliferation and inhibits apoptosis
- (2019) Libao Gong et al. Cancer Medicine
- POM121 overexpression is related to a poor prognosis in colorectal cancer
- (2019) Tengqi Wang et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
- (2019) Annika Jögi et al. PLoS One
- Inhibition of KPNB1 Inhibits Proliferation and Promotes Apoptosis of Chronic Myeloid Leukemia Cells Through Regulation of E2F1
- (2019) Teng Wang et al. OncoTargets and Therapy
- Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress
- (2018) Jiaqiao Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models
- (2018) Cristina Corno et al. BIOCHEMICAL PHARMACOLOGY
- STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma
- (2018) Hadjer Miloudi et al. CELLULAR SIGNALLING
- BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen Resistant Breast Cancer
- (2018) Chun Gong et al. CLINICAL CANCER RESEARCH
- Karyopherins in cancer
- (2018) Tolga Çağatay et al. CURRENT OPINION IN CELL BIOLOGY
- KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells
- (2018) Zhi-Chuan Zhu et al. ONCOGENE
- ARID1A loss in cancer: Towards a mechanistic understanding
- (2018) Radhika Mathur PHARMACOLOGY & THERAPEUTICS
- High Kpnβ1 expression promotes non-small cell lung cancer proliferation and chemoresistance via the PI3-kinase/AKT pathway
- (2018) Haiying Wang et al. TISSUE & CELL
- Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents
- (2018) Trinayan Kashyap et al. Oncotarget
- Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import
- (2018) Veronica Rodriguez-Bravo et al. CELL
- Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor
- (2018) Vinod Vijay Subhash et al. Scientific Reports
- Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems
- (2018) Enyuan Shang et al. Scientific Reports
- Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017
- (2017) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein
- (2017) Muhan Chen et al. JOURNAL OF CELL BIOLOGY
- Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1
- (2017) A Cosson et al. LEUKEMIA
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer
- (2017) Michiko Kodama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Exportin-1–dependent microRNA biogenesis pathway during human cell quiescence
- (2017) Ivan Martinez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A biochemical framework for eIF4E-dependent mRNA export and nuclear recycling of the export machinery
- (2017) Laurent Volpon et al. RNA
- KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells
- (2017) Tamara Stelma et al. Oncotarget
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- The molecular mechanisms of chemoresistance in cancers
- (2017) Hua-Chuan Zheng Oncotarget
- Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells
- (2017) Rand Arafeh et al. Scientific Reports
- Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma
- (2016) Fabrice Jardin et al. AMERICAN JOURNAL OF HEMATOLOGY
- Negative feedback regulation of the ERK1/2 MAPK pathway
- (2016) David Lake et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Identification of KPNB1 as a Cellular Target of Aminothiazole Derivatives with Anticancer Activity
- (2016) Yong-Hak Kim et al. ChemMedChem
- Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer
- (2016) Ying Chen et al. CLINICAL CANCER RESEARCH
- XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase II to the Nucleus
- (2016) P. Ranganathan et al. CLINICAL CANCER RESEARCH
- Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
- (2016) V. Camus et al. HAEMATOLOGICA
- Targeting nuclear transporters in cancer: Diagnostic, prognostic and therapeutic potential
- (2016) Tamara Stelma et al. IUBMB LIFE
- Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors
- (2016) Joel G. Turner et al. Journal of Hematology & Oncology
- KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells
- (2016) J Etchin et al. LEUKEMIA
- Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies
- (2016) Z A Hing et al. LEUKEMIA
- Targeting the Nuclear Import Receptor Kpn 1 as an Anticancer Therapeutic
- (2016) P. J. van der Watt et al. MOLECULAR CANCER THERAPEUTICS
- Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death
- (2016) Trinayan Kashyap et al. Oncotarget
- XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma
- (2016) Joel G. Turner et al. Oncotarget
- Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
- (2016) Robert Nakayama et al. Oncotarget
- Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
- (2016) V. Camus et al. HAEMATOLOGICA
- Synthesis and Biological Evaluation of 2-Aminothiazole Derivative Having Anticancer Activity as a KPNB1 Inhibitor
- (2016) Siyoung Ha et al. BULLETIN OF THE KOREAN CHEMICAL SOCIETY
- ER stress: Autophagy induction, inhibition and selection
- (2015) Harun-Or Rashid et al. Autophagy
- Hyper-dependence of breast cancer cell types on the nuclear transporter Importin β1
- (2015) Henna V. Kuusisto et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The importin α/β-specific inhibitor Ivermectin affects HIF-dependent hypoxia response pathways
- (2015) Friederike K. Kosyna et al. BIOLOGICAL CHEMISTRY
- Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds
- (2015) Marsha Crochiere et al. BMC CANCER
- Importin β1 mediates nuclear factor-κB signal transduction into the nuclei of myeloma cells and affects their proliferation and apoptosis
- (2015) Wenqing Yan et al. CELLULAR SIGNALLING
- Nuclear transport factors: global regulation of mitosis
- (2015) Douglass J Forbes et al. CURRENT OPINION IN CELL BIOLOGY
- Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma
- (2015) Song He et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
- (2015) Shundong Cang et al. Journal of Hematology & Oncology
- Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy
- (2015) Weimin Gao et al. Journal of Thoracic Oncology
- Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma
- (2015) Linlin Yang et al. MEDICAL ONCOLOGY
- Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer
- (2015) S. Kazim et al. MOLECULAR CANCER THERAPEUTICS
- Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185
- (2015) Yoko Tabe et al. PLoS One
- Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
- (2015) Joel D. Leverson et al. Science Translational Medicine
- Upregulation of KPNβ1 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis
- (2015) Jia Zhu et al. TUMOR BIOLOGY
- The nuclear translocation of ERK1/2 as an anticancer target
- (2015) Alexander Plotnikov et al. Nature Communications
- Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
- (2015) N. Murugaesu et al. Cancer Discovery
- Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin
- (2015) Michelandrea De Cesare et al. Oncotarget
- A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning
- (2015) Koray Kırlı et al. eLife
- Targeting nucleocytoplasmic transport in cancer therapy
- (2015) Richard Hill et al. Oncotarget
- KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma
- (2014) Yun Zheng et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma
- (2014) Mariko Yoshimura et al. CANCER SCIENCE
- Inhibition of the nuclear transporter, Kpnβ1, results in prolonged mitotic arrest and activation of the intrinsic apoptotic pathway in cervical cancer cells
- (2014) Liselotte Angus et al. CARCINOGENESIS
- Transportin-1 and Transportin-2: Protein nuclear import and beyond
- (2014) Laure Twyffels et al. FEBS LETTERS
- Transportin acts to regulate mitotic assembly events by target binding rather than Ran sequestration
- (2014) Cyril Bernis et al. MOLECULAR BIOLOGY OF THE CELL
- CBS9106-Induced CRM1 Degradation Is Mediated by Cullin Ring Ligase Activity and the Neddylation Pathway
- (2014) N. Saito et al. MOLECULAR CANCER THERAPEUTICS
- Genomic and molecular characterization of esophageal squamous cell carcinoma
- (2014) De-Chen Lin et al. NATURE GENETICS
- Elevated expression of the nuclear export protein, Crm1 (exportin 1), associates with human oesophageal squamous cell carcinoma
- (2014) PAULINE J. VAN DER WATT et al. ONCOLOGY REPORTS
- ER stress-induced cell death mechanisms
- (2013) Renata Sano et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Prognostic impact and targeting of CRM1 in acute myeloid leukemia
- (2013) K. Kojima et al. BLOOD
- Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276
- (2013) J Schmidt et al. LEUKEMIA
- CRM1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas
- (2013) Fang Zhou et al. MEDICAL ONCOLOGY
- Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
- (2013) P. Godwin et al. Frontiers in Oncology
- ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
- (2012) Guoliang Qing et al. CANCER CELL
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C
- (2012) Annalisa Lorenzato et al. FASEB JOURNAL
- Transient Aggregation of Ubiquitinated Proteins Is a Cytosolic Unfolded Protein Response to Inflammation and Endoplasmic Reticulum Stress
- (2012) Xian-De Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Importin-β negatively regulates multiple aspects of mitosis including RANGAP1 recruitment to kinetochores
- (2012) Emanuele Roscioli et al. JOURNAL OF CELL BIOLOGY
- Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors
- (2012) Ori Kalid et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- CRM1 Blockade by Selective Inhibitors of Nuclear Export Attenuates Kidney Cancer Growth
- (2012) Hiromi Inoue et al. JOURNAL OF UROLOGY
- Importin 7 and Exportin 1 Link c-Myc and p53 to Regulation of Ribosomal Biogenesis
- (2012) Lior Golomb et al. MOLECULAR CELL
- Importazole, a Small Molecule Inhibitor of the Transport Receptor Importin-β
- (2011) Jonathan F. Soderholm et al. ACS Chemical Biology
- The nuclear exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage
- (2011) Pauline J. van der Watt et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Global enhancement of nuclear localization-dependent nuclear transport in transformed cells
- (2011) Henna V. Kuusisto et al. FASEB JOURNAL
- A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
- (2011) Siwanon Jirawatnotai et al. NATURE
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Resistance to BRAF Inhibition in Melanomas
- (2011) David B. Solit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dynamics of the STAT3 Transcription Factor: Nuclear Import Dependent on Ran and Importin-β1
- (2011) Velasco Cimica et al. PLoS One
- Overexpression of Kpnβ1 and Kpnα2 Importin Proteins in Cancer Derives from Deregulated E2F Activity
- (2011) Pauline J. van der Watt et al. PLoS One
- c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin Resistance
- (2011) S. Pyndiah et al. Science Signaling
- mRNA export and cancer
- (2011) Nadeem Siddiqui et al. Wiley Interdisciplinary Reviews-RNA
- Identification of a Small Molecule Inhibitor of Importin β Mediated Nuclear Import by Confocal On-Bead Screening of Tagged One-Bead One-Compound Libraries
- (2010) Martin Hintersteiner et al. ACS Chemical Biology
- Tumor Cell Kill by c-MYC Depletion: Role of MYC-Regulated Genes that Control DNA Double-Strand Break Repair
- (2010) K. R. Luoto et al. CANCER RESEARCH
- Nuclear reformation after mitosis requires downregulation of the Ran GTPase effector RanBP1 in mammalian cells
- (2010) Marilena Ciciarello et al. CHROMOSOMA
- Anti-apoptotic Protein BCL2 Down-regulates DNA End Joining in Cancer Cells
- (2010) Tadi Satish Kumar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A fraction of Crm1 locates at centrosomes by its CRIME domain and regulates the centrosomal localization of pericentrin
- (2009) Qinying Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition
- (2009) J. G. Turner et al. CANCER RESEARCH
- PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers
- (2009) S. Wee et al. CANCER RESEARCH
- Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
- (2009) O. K. Mirzoeva et al. CANCER RESEARCH
- Characterization of Snail nuclear import pathways as representatives of C2H2 zinc finger transcription factors
- (2009) J.-M. Mingot et al. JOURNAL OF CELL SCIENCE
- EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS
- (2009) Aiguo Shen et al. NEUROSURGERY
- Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer
- (2008) Aurelia Noske et al. CANCER
- The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
- (2008) Pauline J. van der Watt et al. INTERNATIONAL JOURNAL OF CANCER
- The RanGTP gradient - a GPS for the mitotic spindle
- (2008) P. Kalab et al. JOURNAL OF CELL SCIENCE
- Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage
- (2008) X. Cai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started